AMP Kinase Activation Increases Glucose Uptake, Decreases Apoptosis, and Improves Pregnancy Outcome in Embryos Exposed to High IGF-I Concentrations

AMP Kinase Activation Increases Glucose Uptake, Decreases Apoptosis, and Improves Pregnancy Outcome in Embryos Exposed to High IGF-I Concentrations Grace S. Eng 1 , Rachael A. Sheridan 2 , Amanda Wyman 2 , Maggie M.-Y. Chi 2 , Kristin P. Bibee 2 , Emily S. Jungheim 2 and Kelle H. Moley 2 1 Departmen...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes (New York, N.Y.) N.Y.), 2007-09, Vol.56 (9), p.2228-2234
Hauptverfasser: ENG, Grace S, SHERIDAN, Rachael A, WYMAN, Amanda, CHI, Maggie M.-Y, BIBEE, Kristin P, JUNGHEIM, Emily S, MOLEY, Kelle H
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2234
container_issue 9
container_start_page 2228
container_title Diabetes (New York, N.Y.)
container_volume 56
creator ENG, Grace S
SHERIDAN, Rachael A
WYMAN, Amanda
CHI, Maggie M.-Y
BIBEE, Kristin P
JUNGHEIM, Emily S
MOLEY, Kelle H
description AMP Kinase Activation Increases Glucose Uptake, Decreases Apoptosis, and Improves Pregnancy Outcome in Embryos Exposed to High IGF-I Concentrations Grace S. Eng 1 , Rachael A. Sheridan 2 , Amanda Wyman 2 , Maggie M.-Y. Chi 2 , Kristin P. Bibee 2 , Emily S. Jungheim 2 and Kelle H. Moley 2 1 Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri 2 Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology, Washington University, St. Louis, Missouri Address correspondence and reprint requests to Kelle H. Moley, Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology, Washington University, 660 South Euclid Ave., Box 8064, St. Louis, MO 63110-1094. E-mail: moleyk{at}wustl.edu Abstract Women with polycystic ovarian syndrome are at increased risk of miscarriage. Although evidence exists that metformin reduces this risk, the mechanism is unknown. This study tests the hypothesis that AMP kinase (AMPK) activation with metformin directly improves insulin signaling within the blastocyst, leading to improved pregnancy outcomes. Murine embryos were exposed to 200 nmol/l IGF-I, similar to the concentrations that can occur during polycystic ovary syndrome (PCOS). Resulting blastocysts were compared with embryos cocultured with excess IGF-I plus metformin and embryos cultured in control medium for the following: AMPK phosphorylation, insulin-stimulated glucose uptake, and apoptosis. Study and control blastocysts were also transferred into control animals. On embryonic day (E) 14.5, resulting fetuses were examined for size and rates of fetal implantation and resorption. Compared with control blastocysts, blastocysts exposed to high concentrations of IGF-I showed a decrease in AMPK activation and insulin-stimulated glucose uptake and an increase in the number of apoptotic nuclei. Blastocysts cocultured in metformin and excess IGF-I performed as well as controls in all studies. 5-Aminoimidazole-4-carboxamide 1-β- d -ribofuranoside, another AMPK activator, also prevented the effects of excess IGF-I on blastocysts. Implantation rates and fetal size at day 14.5 were significantly lower among IGF-I–exposed embryos transferred into control mothers compared with control embryos transferred into control mothers. Both of these parameters were reversed by co-incubation with metformin and IGF-I before transfer. Activation of embryonic AMPK may be the mechanism responsible for the improved pregnancy ou
doi_str_mv 10.2337/db07-0074
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_68209905</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A168630554</galeid><sourcerecordid>A168630554</sourcerecordid><originalsourceid>FETCH-LOGICAL-c515t-fd348531efcefd940d59019f987c190bcf93b26184be3933f142ae232c011e703</originalsourceid><addsrcrecordid>eNpdkd1uEzEQhVcIREPhghdAFhJIFV3wz_75cpWmaURRekEl7iyvdzZ12bW3trc0z8EL45CgSMgXtmY-jc-ckyRvCf5MGSu_tA0uU4zL7FkyI5zxlNHyx_NkhjGhKSl5eZK88v4eY1zE8zI5IWVe5riis-R3_e0GfdVGekC1CvpRBm0NWhnlINY8WvaTsrF5Owb5E87RBfzr1KMdg_XanyNpWrQaRmcfY_3GwcZIo7ZoPQVlB0DaoMXQuK31aPE0xmktChZd6c0dWi0v0xWaW6PABPf3c_86edHJ3sObw32a3F4uvs-v0uv1cjWvr1OVkzykXcuyKmcEOgVdyzPc5hwT3vGqVITjRnWcNbQgVdYA44x1JKMSKKMKEwIlZqfJx_3cKPxhAh_EoL2CvpcG7ORFUVHMOc4j-P4_8N5OzkRtgpIiqzLMWITSPbSRPQhtlDUBnqIBfQ8bEFH5fC1qUlQFw3meRf5szytnvXfQidHpQbqtIFjsYhW7WMUu1si-OwiYmgHaI3nIMQIfDoD0Svadi_5rf-TiFlncJnKf9txdNP-XdiBaLRsI4I-PvBBcUEor9gcT_7fo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>216484033</pqid></control><display><type>article</type><title>AMP Kinase Activation Increases Glucose Uptake, Decreases Apoptosis, and Improves Pregnancy Outcome in Embryos Exposed to High IGF-I Concentrations</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>ENG, Grace S ; SHERIDAN, Rachael A ; WYMAN, Amanda ; CHI, Maggie M.-Y ; BIBEE, Kristin P ; JUNGHEIM, Emily S ; MOLEY, Kelle H</creator><creatorcontrib>ENG, Grace S ; SHERIDAN, Rachael A ; WYMAN, Amanda ; CHI, Maggie M.-Y ; BIBEE, Kristin P ; JUNGHEIM, Emily S ; MOLEY, Kelle H</creatorcontrib><description>AMP Kinase Activation Increases Glucose Uptake, Decreases Apoptosis, and Improves Pregnancy Outcome in Embryos Exposed to High IGF-I Concentrations Grace S. Eng 1 , Rachael A. Sheridan 2 , Amanda Wyman 2 , Maggie M.-Y. Chi 2 , Kristin P. Bibee 2 , Emily S. Jungheim 2 and Kelle H. Moley 2 1 Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri 2 Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology, Washington University, St. Louis, Missouri Address correspondence and reprint requests to Kelle H. Moley, Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology, Washington University, 660 South Euclid Ave., Box 8064, St. Louis, MO 63110-1094. E-mail: moleyk{at}wustl.edu Abstract Women with polycystic ovarian syndrome are at increased risk of miscarriage. Although evidence exists that metformin reduces this risk, the mechanism is unknown. This study tests the hypothesis that AMP kinase (AMPK) activation with metformin directly improves insulin signaling within the blastocyst, leading to improved pregnancy outcomes. Murine embryos were exposed to 200 nmol/l IGF-I, similar to the concentrations that can occur during polycystic ovary syndrome (PCOS). Resulting blastocysts were compared with embryos cocultured with excess IGF-I plus metformin and embryos cultured in control medium for the following: AMPK phosphorylation, insulin-stimulated glucose uptake, and apoptosis. Study and control blastocysts were also transferred into control animals. On embryonic day (E) 14.5, resulting fetuses were examined for size and rates of fetal implantation and resorption. Compared with control blastocysts, blastocysts exposed to high concentrations of IGF-I showed a decrease in AMPK activation and insulin-stimulated glucose uptake and an increase in the number of apoptotic nuclei. Blastocysts cocultured in metformin and excess IGF-I performed as well as controls in all studies. 5-Aminoimidazole-4-carboxamide 1-β- d -ribofuranoside, another AMPK activator, also prevented the effects of excess IGF-I on blastocysts. Implantation rates and fetal size at day 14.5 were significantly lower among IGF-I–exposed embryos transferred into control mothers compared with control embryos transferred into control mothers. Both of these parameters were reversed by co-incubation with metformin and IGF-I before transfer. Activation of embryonic AMPK may be the mechanism responsible for the improved pregnancy outcomes seen in PCOS patients taking metformin. AICAR, 5-aminoimidazole-4-carboxamide 1-β-d-ribofuranoside AMPK, AMP kinase DPCPX, 1,3-dipropyl-8-cyclopentylxanthine E, embryonic day hCG, human chorionic gonadotropin HTF, human tubal fluid IGFBP-1, IGF binding protein-1 PCOS, polycystic ovary syndrome TBST, Tris-buffered saline with Tween TUNEL, transferase-mediated dUTP nick-end labeling Footnotes Published ahead of print at http://diabetes.diabetesjournals.org on 15 June 2007. DOI: 10.2337/db07-0074. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Accepted June 8, 2007. Received January 16, 2007. DIABETES</description><identifier>ISSN: 0012-1797</identifier><identifier>EISSN: 1939-327X</identifier><identifier>DOI: 10.2337/db07-0074</identifier><identifier>PMID: 17575082</identifier><identifier>CODEN: DIAEAZ</identifier><language>eng</language><publisher>Alexandria, VA: American Diabetes Association</publisher><subject>Adenylate Kinase - metabolism ; Aminoimidazole Carboxamide - analogs &amp; derivatives ; Aminoimidazole Carboxamide - pharmacology ; Animals ; Apoptosis ; Apoptosis - drug effects ; Apoptosis - physiology ; Biological and medical sciences ; Care and treatment ; Diabetes ; Diabetes. Impaired glucose tolerance ; Embryos ; Endocrine pancreas. Apud cells (diseases) ; Endocrinopathies ; Enzyme Activation ; Etiopathogenesis. Screening. Investigations. Target tissue resistance ; Female ; Glucose ; Glucose - metabolism ; Health aspects ; Infertility ; Insulin resistance ; Insulin-Like Growth Factor I - pharmacology ; Insulin-like growth factors ; Kinases ; Medical sciences ; Metformin - pharmacology ; Mice ; Mice, Inbred Strains ; Miscarriage ; Ovaries ; Polycystic ovary syndrome ; Pregnancy ; Pregnancy Outcome ; Pregnant women ; Ribonucleotides - pharmacology ; Risk factors ; Stein-Leventhal syndrome ; Superovulation</subject><ispartof>Diabetes (New York, N.Y.), 2007-09, Vol.56 (9), p.2228-2234</ispartof><rights>2007 INIST-CNRS</rights><rights>COPYRIGHT 2007 American Diabetes Association</rights><rights>Copyright American Diabetes Association Sep 2007</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c515t-fd348531efcefd940d59019f987c190bcf93b26184be3933f142ae232c011e703</citedby><cites>FETCH-LOGICAL-c515t-fd348531efcefd940d59019f987c190bcf93b26184be3933f142ae232c011e703</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=19054820$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17575082$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>ENG, Grace S</creatorcontrib><creatorcontrib>SHERIDAN, Rachael A</creatorcontrib><creatorcontrib>WYMAN, Amanda</creatorcontrib><creatorcontrib>CHI, Maggie M.-Y</creatorcontrib><creatorcontrib>BIBEE, Kristin P</creatorcontrib><creatorcontrib>JUNGHEIM, Emily S</creatorcontrib><creatorcontrib>MOLEY, Kelle H</creatorcontrib><title>AMP Kinase Activation Increases Glucose Uptake, Decreases Apoptosis, and Improves Pregnancy Outcome in Embryos Exposed to High IGF-I Concentrations</title><title>Diabetes (New York, N.Y.)</title><addtitle>Diabetes</addtitle><description>AMP Kinase Activation Increases Glucose Uptake, Decreases Apoptosis, and Improves Pregnancy Outcome in Embryos Exposed to High IGF-I Concentrations Grace S. Eng 1 , Rachael A. Sheridan 2 , Amanda Wyman 2 , Maggie M.-Y. Chi 2 , Kristin P. Bibee 2 , Emily S. Jungheim 2 and Kelle H. Moley 2 1 Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri 2 Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology, Washington University, St. Louis, Missouri Address correspondence and reprint requests to Kelle H. Moley, Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology, Washington University, 660 South Euclid Ave., Box 8064, St. Louis, MO 63110-1094. E-mail: moleyk{at}wustl.edu Abstract Women with polycystic ovarian syndrome are at increased risk of miscarriage. Although evidence exists that metformin reduces this risk, the mechanism is unknown. This study tests the hypothesis that AMP kinase (AMPK) activation with metformin directly improves insulin signaling within the blastocyst, leading to improved pregnancy outcomes. Murine embryos were exposed to 200 nmol/l IGF-I, similar to the concentrations that can occur during polycystic ovary syndrome (PCOS). Resulting blastocysts were compared with embryos cocultured with excess IGF-I plus metformin and embryos cultured in control medium for the following: AMPK phosphorylation, insulin-stimulated glucose uptake, and apoptosis. Study and control blastocysts were also transferred into control animals. On embryonic day (E) 14.5, resulting fetuses were examined for size and rates of fetal implantation and resorption. Compared with control blastocysts, blastocysts exposed to high concentrations of IGF-I showed a decrease in AMPK activation and insulin-stimulated glucose uptake and an increase in the number of apoptotic nuclei. Blastocysts cocultured in metformin and excess IGF-I performed as well as controls in all studies. 5-Aminoimidazole-4-carboxamide 1-β- d -ribofuranoside, another AMPK activator, also prevented the effects of excess IGF-I on blastocysts. Implantation rates and fetal size at day 14.5 were significantly lower among IGF-I–exposed embryos transferred into control mothers compared with control embryos transferred into control mothers. Both of these parameters were reversed by co-incubation with metformin and IGF-I before transfer. Activation of embryonic AMPK may be the mechanism responsible for the improved pregnancy outcomes seen in PCOS patients taking metformin. AICAR, 5-aminoimidazole-4-carboxamide 1-β-d-ribofuranoside AMPK, AMP kinase DPCPX, 1,3-dipropyl-8-cyclopentylxanthine E, embryonic day hCG, human chorionic gonadotropin HTF, human tubal fluid IGFBP-1, IGF binding protein-1 PCOS, polycystic ovary syndrome TBST, Tris-buffered saline with Tween TUNEL, transferase-mediated dUTP nick-end labeling Footnotes Published ahead of print at http://diabetes.diabetesjournals.org on 15 June 2007. DOI: 10.2337/db07-0074. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Accepted June 8, 2007. Received January 16, 2007. DIABETES</description><subject>Adenylate Kinase - metabolism</subject><subject>Aminoimidazole Carboxamide - analogs &amp; derivatives</subject><subject>Aminoimidazole Carboxamide - pharmacology</subject><subject>Animals</subject><subject>Apoptosis</subject><subject>Apoptosis - drug effects</subject><subject>Apoptosis - physiology</subject><subject>Biological and medical sciences</subject><subject>Care and treatment</subject><subject>Diabetes</subject><subject>Diabetes. Impaired glucose tolerance</subject><subject>Embryos</subject><subject>Endocrine pancreas. Apud cells (diseases)</subject><subject>Endocrinopathies</subject><subject>Enzyme Activation</subject><subject>Etiopathogenesis. Screening. Investigations. Target tissue resistance</subject><subject>Female</subject><subject>Glucose</subject><subject>Glucose - metabolism</subject><subject>Health aspects</subject><subject>Infertility</subject><subject>Insulin resistance</subject><subject>Insulin-Like Growth Factor I - pharmacology</subject><subject>Insulin-like growth factors</subject><subject>Kinases</subject><subject>Medical sciences</subject><subject>Metformin - pharmacology</subject><subject>Mice</subject><subject>Mice, Inbred Strains</subject><subject>Miscarriage</subject><subject>Ovaries</subject><subject>Polycystic ovary syndrome</subject><subject>Pregnancy</subject><subject>Pregnancy Outcome</subject><subject>Pregnant women</subject><subject>Ribonucleotides - pharmacology</subject><subject>Risk factors</subject><subject>Stein-Leventhal syndrome</subject><subject>Superovulation</subject><issn>0012-1797</issn><issn>1939-327X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNpdkd1uEzEQhVcIREPhghdAFhJIFV3wz_75cpWmaURRekEl7iyvdzZ12bW3trc0z8EL45CgSMgXtmY-jc-ckyRvCf5MGSu_tA0uU4zL7FkyI5zxlNHyx_NkhjGhKSl5eZK88v4eY1zE8zI5IWVe5riis-R3_e0GfdVGekC1CvpRBm0NWhnlINY8WvaTsrF5Owb5E87RBfzr1KMdg_XanyNpWrQaRmcfY_3GwcZIo7ZoPQVlB0DaoMXQuK31aPE0xmktChZd6c0dWi0v0xWaW6PABPf3c_86edHJ3sObw32a3F4uvs-v0uv1cjWvr1OVkzykXcuyKmcEOgVdyzPc5hwT3vGqVITjRnWcNbQgVdYA44x1JKMSKKMKEwIlZqfJx_3cKPxhAh_EoL2CvpcG7ORFUVHMOc4j-P4_8N5OzkRtgpIiqzLMWITSPbSRPQhtlDUBnqIBfQ8bEFH5fC1qUlQFw3meRf5szytnvXfQidHpQbqtIFjsYhW7WMUu1si-OwiYmgHaI3nIMQIfDoD0Svadi_5rf-TiFlncJnKf9txdNP-XdiBaLRsI4I-PvBBcUEor9gcT_7fo</recordid><startdate>20070901</startdate><enddate>20070901</enddate><creator>ENG, Grace S</creator><creator>SHERIDAN, Rachael A</creator><creator>WYMAN, Amanda</creator><creator>CHI, Maggie M.-Y</creator><creator>BIBEE, Kristin P</creator><creator>JUNGHEIM, Emily S</creator><creator>MOLEY, Kelle H</creator><general>American Diabetes Association</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>S0X</scope><scope>7X8</scope></search><sort><creationdate>20070901</creationdate><title>AMP Kinase Activation Increases Glucose Uptake, Decreases Apoptosis, and Improves Pregnancy Outcome in Embryos Exposed to High IGF-I Concentrations</title><author>ENG, Grace S ; SHERIDAN, Rachael A ; WYMAN, Amanda ; CHI, Maggie M.-Y ; BIBEE, Kristin P ; JUNGHEIM, Emily S ; MOLEY, Kelle H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c515t-fd348531efcefd940d59019f987c190bcf93b26184be3933f142ae232c011e703</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Adenylate Kinase - metabolism</topic><topic>Aminoimidazole Carboxamide - analogs &amp; derivatives</topic><topic>Aminoimidazole Carboxamide - pharmacology</topic><topic>Animals</topic><topic>Apoptosis</topic><topic>Apoptosis - drug effects</topic><topic>Apoptosis - physiology</topic><topic>Biological and medical sciences</topic><topic>Care and treatment</topic><topic>Diabetes</topic><topic>Diabetes. Impaired glucose tolerance</topic><topic>Embryos</topic><topic>Endocrine pancreas. Apud cells (diseases)</topic><topic>Endocrinopathies</topic><topic>Enzyme Activation</topic><topic>Etiopathogenesis. Screening. Investigations. Target tissue resistance</topic><topic>Female</topic><topic>Glucose</topic><topic>Glucose - metabolism</topic><topic>Health aspects</topic><topic>Infertility</topic><topic>Insulin resistance</topic><topic>Insulin-Like Growth Factor I - pharmacology</topic><topic>Insulin-like growth factors</topic><topic>Kinases</topic><topic>Medical sciences</topic><topic>Metformin - pharmacology</topic><topic>Mice</topic><topic>Mice, Inbred Strains</topic><topic>Miscarriage</topic><topic>Ovaries</topic><topic>Polycystic ovary syndrome</topic><topic>Pregnancy</topic><topic>Pregnancy Outcome</topic><topic>Pregnant women</topic><topic>Ribonucleotides - pharmacology</topic><topic>Risk factors</topic><topic>Stein-Leventhal syndrome</topic><topic>Superovulation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>ENG, Grace S</creatorcontrib><creatorcontrib>SHERIDAN, Rachael A</creatorcontrib><creatorcontrib>WYMAN, Amanda</creatorcontrib><creatorcontrib>CHI, Maggie M.-Y</creatorcontrib><creatorcontrib>BIBEE, Kristin P</creatorcontrib><creatorcontrib>JUNGHEIM, Emily S</creatorcontrib><creatorcontrib>MOLEY, Kelle H</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><jtitle>Diabetes (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>ENG, Grace S</au><au>SHERIDAN, Rachael A</au><au>WYMAN, Amanda</au><au>CHI, Maggie M.-Y</au><au>BIBEE, Kristin P</au><au>JUNGHEIM, Emily S</au><au>MOLEY, Kelle H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>AMP Kinase Activation Increases Glucose Uptake, Decreases Apoptosis, and Improves Pregnancy Outcome in Embryos Exposed to High IGF-I Concentrations</atitle><jtitle>Diabetes (New York, N.Y.)</jtitle><addtitle>Diabetes</addtitle><date>2007-09-01</date><risdate>2007</risdate><volume>56</volume><issue>9</issue><spage>2228</spage><epage>2234</epage><pages>2228-2234</pages><issn>0012-1797</issn><eissn>1939-327X</eissn><coden>DIAEAZ</coden><abstract>AMP Kinase Activation Increases Glucose Uptake, Decreases Apoptosis, and Improves Pregnancy Outcome in Embryos Exposed to High IGF-I Concentrations Grace S. Eng 1 , Rachael A. Sheridan 2 , Amanda Wyman 2 , Maggie M.-Y. Chi 2 , Kristin P. Bibee 2 , Emily S. Jungheim 2 and Kelle H. Moley 2 1 Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri 2 Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology, Washington University, St. Louis, Missouri Address correspondence and reprint requests to Kelle H. Moley, Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology, Washington University, 660 South Euclid Ave., Box 8064, St. Louis, MO 63110-1094. E-mail: moleyk{at}wustl.edu Abstract Women with polycystic ovarian syndrome are at increased risk of miscarriage. Although evidence exists that metformin reduces this risk, the mechanism is unknown. This study tests the hypothesis that AMP kinase (AMPK) activation with metformin directly improves insulin signaling within the blastocyst, leading to improved pregnancy outcomes. Murine embryos were exposed to 200 nmol/l IGF-I, similar to the concentrations that can occur during polycystic ovary syndrome (PCOS). Resulting blastocysts were compared with embryos cocultured with excess IGF-I plus metformin and embryos cultured in control medium for the following: AMPK phosphorylation, insulin-stimulated glucose uptake, and apoptosis. Study and control blastocysts were also transferred into control animals. On embryonic day (E) 14.5, resulting fetuses were examined for size and rates of fetal implantation and resorption. Compared with control blastocysts, blastocysts exposed to high concentrations of IGF-I showed a decrease in AMPK activation and insulin-stimulated glucose uptake and an increase in the number of apoptotic nuclei. Blastocysts cocultured in metformin and excess IGF-I performed as well as controls in all studies. 5-Aminoimidazole-4-carboxamide 1-β- d -ribofuranoside, another AMPK activator, also prevented the effects of excess IGF-I on blastocysts. Implantation rates and fetal size at day 14.5 were significantly lower among IGF-I–exposed embryos transferred into control mothers compared with control embryos transferred into control mothers. Both of these parameters were reversed by co-incubation with metformin and IGF-I before transfer. Activation of embryonic AMPK may be the mechanism responsible for the improved pregnancy outcomes seen in PCOS patients taking metformin. AICAR, 5-aminoimidazole-4-carboxamide 1-β-d-ribofuranoside AMPK, AMP kinase DPCPX, 1,3-dipropyl-8-cyclopentylxanthine E, embryonic day hCG, human chorionic gonadotropin HTF, human tubal fluid IGFBP-1, IGF binding protein-1 PCOS, polycystic ovary syndrome TBST, Tris-buffered saline with Tween TUNEL, transferase-mediated dUTP nick-end labeling Footnotes Published ahead of print at http://diabetes.diabetesjournals.org on 15 June 2007. DOI: 10.2337/db07-0074. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Accepted June 8, 2007. Received January 16, 2007. DIABETES</abstract><cop>Alexandria, VA</cop><pub>American Diabetes Association</pub><pmid>17575082</pmid><doi>10.2337/db07-0074</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0012-1797
ispartof Diabetes (New York, N.Y.), 2007-09, Vol.56 (9), p.2228-2234
issn 0012-1797
1939-327X
language eng
recordid cdi_proquest_miscellaneous_68209905
source MEDLINE; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Adenylate Kinase - metabolism
Aminoimidazole Carboxamide - analogs & derivatives
Aminoimidazole Carboxamide - pharmacology
Animals
Apoptosis
Apoptosis - drug effects
Apoptosis - physiology
Biological and medical sciences
Care and treatment
Diabetes
Diabetes. Impaired glucose tolerance
Embryos
Endocrine pancreas. Apud cells (diseases)
Endocrinopathies
Enzyme Activation
Etiopathogenesis. Screening. Investigations. Target tissue resistance
Female
Glucose
Glucose - metabolism
Health aspects
Infertility
Insulin resistance
Insulin-Like Growth Factor I - pharmacology
Insulin-like growth factors
Kinases
Medical sciences
Metformin - pharmacology
Mice
Mice, Inbred Strains
Miscarriage
Ovaries
Polycystic ovary syndrome
Pregnancy
Pregnancy Outcome
Pregnant women
Ribonucleotides - pharmacology
Risk factors
Stein-Leventhal syndrome
Superovulation
title AMP Kinase Activation Increases Glucose Uptake, Decreases Apoptosis, and Improves Pregnancy Outcome in Embryos Exposed to High IGF-I Concentrations
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T01%3A01%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=AMP%20Kinase%20Activation%20Increases%20Glucose%20Uptake,%20Decreases%20Apoptosis,%20and%20Improves%20Pregnancy%20Outcome%20in%20Embryos%20Exposed%20to%20High%20IGF-I%20Concentrations&rft.jtitle=Diabetes%20(New%20York,%20N.Y.)&rft.au=ENG,%20Grace%20S&rft.date=2007-09-01&rft.volume=56&rft.issue=9&rft.spage=2228&rft.epage=2234&rft.pages=2228-2234&rft.issn=0012-1797&rft.eissn=1939-327X&rft.coden=DIAEAZ&rft_id=info:doi/10.2337/db07-0074&rft_dat=%3Cgale_proqu%3EA168630554%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=216484033&rft_id=info:pmid/17575082&rft_galeid=A168630554&rfr_iscdi=true